Browsing Tag
SHP2 inhibitor
1 post
InnoCare Pharma, ArriVent BioPharma initiate Phase 1b clinical trial in NSCLC
InnoCare Pharma, listed on both the Hong Kong Stock Exchange (HKEX: 09969) and the Shanghai Stock Exchange (SSE:…